MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

||
||

Income Overview

Revenue
$450K
Net Income
-$20,739K
Net Profit Margin
-4608.67%
EPS
-$4.88
Unit: Thousand (K) dollars
Income Statement
2026-06-30
Total revenue
450
Research and development (including related party amounts of 178 and 34 for the three months ended june 30, 2026 and 2025, respectively, and 238 and 41 for the six months ended june 30, 2026 and 2025, respectively)
18,946
General and administrative (including related party amounts of 0 for the three months ended june 30, 2026 and 2025, and 0 and 239 for the six months ended june 30, 2026 and 2025, respectively)
3,307
Total operating expenses
22,253
Loss from operations
-21,803
Interest income
1,141
Change in fair value of preferred stock tranche liability
0
Other income (expense), net
-25
Total other income (expense), net
1,116
Net loss
-20,687
Less accretion of redeemable convertible preferred stock to its redemption value
0
Net loss attributable to common stockholders
-20,687
Unrealized loss on available-for-sale marketable securities, net
-52
Net loss and other comprehensive loss
-20,739
Basic EPS
-4.88
Diluted EPS
-4.88
Basic Average Shares
4,237,597
Diluted Average Shares
4,237,597
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss and othercomprehensive loss-$20,739K Net lossattributable to common...-$20,687K Unrealized loss onavailable-for-sale marketable...-$52K Interest income$1,141K Net loss-$20,687K Total other income(expense), net$1,116K Other income(expense), net-$25K Loss from operations-$21,803K Total revenue$450K Total operatingexpenses$22,253K Research and development(including related party...$18,946K General andadministrative (including...$3,307K

Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics, Inc. (ATTO)